CLINICAL_TRIALS
trial_result
· 2009-08-11
Clinical Trial Update: Study of Erbitux™ (Cetuximab) in Pediatric Patients With Refractory Solid Tumors [Phase 1]
Summary
Phase 1 study update of cetuximab (Erbitux) in pediatric patients with refractory solid tumors; the trial completed and results were posted in 2009.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Cancer, Refractory Solid Tumor | Phase 1 | Status: COMPLETED | Results posted: 2009-08-11